← Back to All Filings
Teva Interim CLO Exercises Options and Sells 7,342 Shares
TEVA PHARMACEUTICAL INDUSTRIES LTD
$TEVA4CIK: 0000818686
Subscribe to track TEVA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA)
Insider: Savage Brian (Interim Chief Legal Officer)
Type: Option Exercise & Sale | Date: 2026-09-18
Shares Sold: 7,342 @ ~$38.85 (~$285.2K total)
Shares Acquired (Exercise): 4,503 @ $34.70 (~$156.3K cost)
Remaining Direct Holdings: 8,500 shares
Significance: Low (Routine option exercise & liquidity event)
Comprehensive Analysis
Executive Summary
On September 18, 2026, Brian Savage, Interim Chief Legal Officer of Teva Pharmaceutical Industries Ltd ($TEVA), executed a series of transactions including an option exercise and open-market share dispositions:
- Option Exercise: Exercised 4,503 stock options with an exercise price of $34.70 per share ($156,254.10 total cost).
- Open-Market Sales: Disposed of 7,342 Ordinary Shares across three tranches for a combined value of approximately $285,215.19:
- 4,503 shares at $38.69
- 2,525 shares at a weighted-average price of $39.145
- 314 shares at $38.7038
Following these transactions, Brian Savage directly holds 8,500 Ordinary Shares.
Transaction Significance
- Trading Significance: Low. The disposition represents a standard exercise-and-sell of options approaching their March 2027 expiration date, alongside a minor trimming of existing shares.
- Transaction Size: Total gross sale proceeds of ~$285.2K represent a modest transaction volume relative to overall market liquidity in TEVA.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.